Strongyloides stercoralis-induced sepsis and acute respiratory distress syndrome in a patient with Guillain-Barré syndrome

doi:10.5847/wjem.j.1920-8642.2024.063

World Journal of Emergency Medicine ›› 2024, Vol. 15 ›› Issue (5): 413-415.doi: 10.5847/wjem.j.1920-8642.2024.063

• Case Letters • Previous Articles Next Articles

Strongyloides stercoralis-induced sepsis and acute respiratory distress syndrome in a patient with Guillain-Barré syndrome

Juhao Zeng¹, Yin Wen¹, Hongguang Ding², Dongxin Li²(), Hongke Zeng¹

¹Department of Critical Care Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
²Emergency Department, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China

Received:2024-03-10 Online:2024-09-09 Published:2024-09-01
Contact: Dongxin Li, Email: lidongxin@gdph.org.cn

Abstract

Juhao Zeng, Yin Wen, Hongguang Ding, Dongxin Li, Hongke Zeng. Strongyloides stercoralis-induced sepsis and acute respiratory distress syndrome in a patient with Guillain-Barré syndrome[J]. World Journal of Emergency Medicine, 2024, 15(5): 413-415.

Laboratory values	Day 1	Day 2	Day 3	Day 4	Day 5	Day 6	Day 7	Day 12	Day 21	Day 27
WBC, ×10⁹/L	8.58	9.50	10.10	10.50	7.80	6.53	8.14	9.68	8.62	7.43
NEUT, ×10⁹/L	7.70	8.35	8.87	8.97	6.89	4.44	5.64	6.80	4.21	3.51
EOS, ×10⁹/L	0.01	0.28	0.37	0.77	1.30	1.11	1.10	0.70	1.28	0.60
PLT, ×10⁹/L	144	122	136	122	119	127	131	141	154	174
PCT, ng/ml	3.08	15.99	5.66	3.46	1.86	1.16	1.72	3.68	0.30	0.42
CRP, ng/ml	200	200	200	200	200	147	100	86	59	52
LAC, mmol/L	2.50	1.60	0.90	1.10	1.00	1.20	1.23	0.85	0.92	1.12
Oxygenation index	123	180	152	125	127	182	193	256	389	422
NT-proBNP, pg/mL	4,903	2,689	1,793	607	345	142	134	124	112	85

1	Gordon CA, Utzinger J, Muhi S, Becker SL, Keiser J, Khieu V, et al. Strongyloidiasis. Nat Rev Dis Primers. 2024 ;10(1):6.
2	Esterman E, Goyen TA, Jani P, Lowe G, Baird J, Maheshwari R, et al. Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants. World J Pediatr. 2023 ;19(6):586-94.
3	Gandasegui J, Muñoz J, Fleitas P, Mazzi C, Bisoffi Z. Moxidectin versus ivermectin for strongyloidiasis control. Lancet Infect Dis. 2024 ;24(3):e152.
4	Suputtamongkol Y, Kungpanichkul N, Silpasakorn S, Beeching NJ. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. Int J Antimicrob Agents. 2008 ;31(1):46-9.

Strongyloides stercoralis-induced sepsis and acute respiratory distress syndrome in a patient with Guillain-Barré syndrome

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 4

Related Articles 0

Recommended Articles

Comments